Showing results (61-70 of 135) with videos related to

Sort By:
Pageof 14
Journal of Hepatology|July 17, 2016
Comparison of no-touch multi-bipolar vs. monopolar radiofrequency ablation for small HCCArnaud Hocquelet, Christophe Aubé, Agnès Rode, et al.
Theranostics|October 12, 2020
Restoration of RNA helicase DDX5 suppresses hepatitis B virus (HBV) biosynthesis and Wnt signaling in HBV-related hepatocellular carcinomaSaravana Kumar Kailasam Mani, Bingyu Yan, Zhibin Cui, et al.
Journal of Hepatology|November 9, 2010
Pharmacological inhibition of Frizzled-7 displays anti-tumor properties in hepatocellular carcinomaSarah Beseme Nambotin, Lydie Lefrancois, Xavier Sainsily, et al.
AIDS (London, England)|April 18, 2023
Mortality in hepatitis C virus-cured vs. hepatitis C virus-uninfected people with HIVMaria-Bernarda Requena, Sophie Grabar, Emilie Lanoy, et al.
Liver Cancer|December 17, 2024
Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma with Main Trunk and/or Contralateral Portal Vein Invasion in IMbrave150Richard S Finn, Peter R Galle, Michel Ducreux, et al.
Plos One|March 24, 2017
Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinomaReetta Holmila, Athena Sklias, David C Muller, et al.
The Journal of Experimental Medicine|August 21, 2002
Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibodyAlain P Vicari, Claudia Chiodoni, Céline Vaure, et al.
Therapeutic Advances in Medical Oncology|August 7, 2023
Beyond atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma: overall efficacy and safety of tyrosine kinase inhibitors in a real-world settingManon Falette-Puisieux, Jean-Charles Nault, Mohamed Bouattour, et al.
Experimental Cell Research|September 27, 2019
In vitro transformation of primary human hepatocytes: Epigenetic changes and stemness propertiesFloriane Pez, Patricia Gifu, Davide Degli-Esposti, et al.
Plos One|October 7, 2025
Frizzled 7 drives amplification of cancer stem-cell subpopulations and the aggressiveness and poor differentiation of human hepatocellular carcinomaAnaïs Lopez, Alexia Paturel, Nadim Fares, et al.
Pageof 14